 |
|
|
| |
Cost and Effectiveness of combining treatment on Day 1 (Rapid Start) for hepatitis C and higher screening effort in at-risk populations (T&T strategy) in France
|
| |
| |
EASL International Liver Congress, June 23-26, 2021
JB. TRABUT1, M. BOURLIERE2, I. RODRIGUEZ3, O. LADA4, M. BLACHIER5, C. HEZODE6, H. LELEU7
1 Service d'addictologie, Hopital Henri Mondor, Creteil; 2 Service d'hepato-gastroenterologie, hopital Saint-Joseph, Marseille; 3,4,6 Gilead, Boulogne-Billancourt; 5,7 Public health expertise, Paris
|
| |
|
|
|
|
|
